Key result
Treatment with 1 mg/kg corticosteroids led to the improvement of eosinophil and platelet counts in a patient with hypereosinophilic syndrome, myocarditis, and stroke secondary to COVID-19.
Case Report (n=1)
This case highlights the potential for hypereosinophilic syndrome secondary to asymptomatic COVID-19 infection to cause severe complications like myocarditis and stroke, which can be managed with corticosteroids.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Poursadrolah et al. (2024) conducted a case report in Hypereosinophilic Syndrome with COVID-19 (n=1). Corticosteroids was evaluated on Improvement of eosinophil and platelet count. Treatment with 1 mg/kg corticosteroids led to the improvement of eosinophil and platelet counts in a patient with hypereosinophilic syndrome, myocarditis, and stroke secondary to COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: